Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 30, Issue 3, March 2005, Pages 237-327
 
MONOGRAPHS
 
  
 AMG-162.
Treatment of osteoporosis, Bone cancer therapy, Treatment of rheumatoid arthritis, Human anti-RANKL monoclonal antibody.
McIntyre, J.A., Martin, L.
Drugs Fut 2005, 30(3): 237
Summary | Full Text: HTMLPDF 
 
  
  
 Matuzumab.
Solid tumor therapy, Humanized anti-EGFR monoclonal antibody.
Sorbera, L.A., Bozzo, J., Bayes, M.
Drugs Fut 2005, 30(3): 240
Summary | Full Text: HTMLPDF 
 
  
  
 SGS-742.
Treatment of Alzheimer's dementia, Treatment of attention deficit hyperactivity disorder, GABAB receptor antagonist.
Davies, S., Castaner, J., Castaner, R.M.
Drugs Fut 2005, 30(3): 248
Summary | Full Text: HTMLPDF 
 
  
  
 Taltobulin.
Oncolytic drug, Tubulin polymerization inhibitor, Antimitotic drug
Ayral-Kaloustian, S., Zask, A.
Drugs Fut 2005, 30(3): 254
Summary | Full Text: HTMLPDF 
 
  
 
REVIEW ARTICLES
 
  
 Cytochrome P-450: a new target in the heart and coronary circulation.
Doggrell, S.A.
Drugs Fut 2005, 30(3): 261
Summary | Full Text: HTMLPDF 
 
  
  
 Development of the RapidMistTM drug delivery system for the treatment of diabetes, cardiovascular diseases and breakthrough cancer pain.
Modi, P.
Drugs Fut 2005, 30(3): 271
Summary | Full Text: HTMLPDF 
 
  
  
 Discovery of natural product inhibitors of HIV-1 integrase at Merck.
Singh, S.B., Pelaez, F., Hazuda, D.J., Lingham, R.B.
Drugs Fut 2005, 30(3): 277
Summary | Full Text: HTMLPDF 
 
  
  
 DNA minor groove binding agents.
Damia, G., Broggini, M.
Drugs Fut 2005, 30(3): 301
Summary | Full Text: HTMLPDF 
 
  
  
 Nuclear molecular imaging: a novel means fo drug discovery in gene therapy?.
Pauwels, E.K.J.
Drugs Fut 2005, 30(3): 311
Summary | Full Text: HTMLPDF 
 
  
  
 Pharmacological approaches for the treatment of strabismus.
McLoon, L.K., Christiansen, S.P.
Drugs Fut 2005, 30(3): 319
Summary | Full Text: HTMLPDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy